Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2012; 18(41): 5972-5978
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5972
Published online Nov 7, 2012. doi: 10.3748/wjg.v18.i41.5972
Age/sex | Principal disease | Drug | Dose (mg/d) | Treatment duration (d) | Peak values | Follow-up | ||||
ALT (U/L) | AST (U/L) | AP (U/L) | TB (mg/dL) | GGT (U/L) | ||||||
20/F | SLE | MP | 20-160 | 84 | 600 | 138 | 83 | 2.31 | 183 | Recovered |
36/F | Chronic glomerulonephritis | MP | 32-40 | 17 | 1085 | 439 | 162 | 0.34 | 41 | Improved |
25/M | Brain trauma | MP | 20 | 10 | 515 | 257 | 148 | 0.61 | 446 | Improved |
49/M | Brain trauma | MP | 40 | 10 | 516 | 363 | 108 | 1.19 | 190 | Improved |
42/F | Drug eruption | MP | 30-160 | 24 | 668 | 34 | 110 | 0.61 | 146 | Improved |
49/M | Brain tumor | DXM | 5-15 | 12 | 602 | 282 | 231 | 0.52 | 424 | Improved |
- Citation: Xu HM, Chen Y, Xu J, Zhou Q. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase. World J Gastroenterol 2012; 18(41): 5972-5978
- URL: https://www.wjgnet.com/1007-9327/full/v18/i41/5972.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i41.5972